255 related articles for article (PubMed ID: 21327901)
21. Misuse of tumor marker levels leads to an insufficient International Germ Cell Consensus Classification (IGCCCG) risk group assignment and impaired treatment.
Majewski M; Paffenholz P; Ruf C; Che Y; Seidel C; Heinzelbecker J; Schmelz HU; Matthies C; Albers P; Bokemeyer C; Heidenreich A; Pichler M; Nestler T;
Cancer Med; 2023 Aug; 12(16):16829-16836. PubMed ID: 37392170
[TBL] [Abstract][Full Text] [Related]
22. [Tumor marker diagnosis in non-seminomatous testicular tumors using human chorionic gonadotropin (HCG) and alpha fetoprotein (AFP)].
Boewer C; Nawka S; Fleck H; Uibel M; Immer U; Schmidt HE; Herzmann H; Pilgrim G; Ziegenbein R
Z Urol Nephrol; 1985 Feb; 78(2):77-86. PubMed ID: 2581393
[TBL] [Abstract][Full Text] [Related]
23. Real-World Application of Pre-Orchiectomy miR-371a-3p Test in Testicular Germ Cell Tumor Management.
Badia RR; Abe D; Wong D; Singla N; Savelyeva A; Chertack N; Woldu SL; Lotan Y; Mauck R; Ouyang D; Meng X; Lewis CM; Majmudar K; Jia L; Kapur P; Xu L; Frazier AL; Margulis V; Strand DW; Coleman N; Murray MJ; Amatruda JF; Lafin JT; Bagrodia A
J Urol; 2021 Jan; 205(1):137-144. PubMed ID: 32856980
[TBL] [Abstract][Full Text] [Related]
24. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
[TBL] [Abstract][Full Text] [Related]
25. The utility of lactate dehydrogenase in the follow-up of testicular germ cell tumours.
Venkitaraman R; Johnson B; Huddart RA; Parker CC; Horwich A; Dearnaley DP
BJU Int; 2007 Jul; 100(1):30-2. PubMed ID: 17552950
[TBL] [Abstract][Full Text] [Related]
26. Serum tumour markers in testicular and extragonadal germ cell malignancies.
Klepp O
Scand J Clin Lab Invest Suppl; 1991; 206():28-41. PubMed ID: 1947758
[TBL] [Abstract][Full Text] [Related]
27. Serum tumor markers and testicular germ cell tumors: a primer for radiologists.
Marshall C; Enzerra M; Rahnemai-Azar AA; Ramaiya NH
Abdom Radiol (NY); 2019 Mar; 44(3):1083-1090. PubMed ID: 30539249
[TBL] [Abstract][Full Text] [Related]
28. Safety of surveillance in the management of stage I anaplastic germ cell tumours of the testis.
Crawford SM; Rustin GJ; Begent RH; Newlands ES; Bagshawe KD
Br J Urol; 1988 Mar; 61(3):250-3. PubMed ID: 2833974
[TBL] [Abstract][Full Text] [Related]
29. Serum human chorionic gonadotropin is associated with angiogenesis in germ cell testicular tumors.
Arrieta O; Michel Ortega RM; Angeles-Sánchez J; Villarreal-Garza C; Avilés-Salas A; Chanona-Vilchis JG; Aréchaga-Ocampo E; Luévano-González A; Jiménez MA; Aguilar JL
J Exp Clin Cancer Res; 2009 Aug; 28(1):120. PubMed ID: 19709439
[TBL] [Abstract][Full Text] [Related]
30. microRNA-371a-3p as informative biomarker for the follow-up of testicular germ cell cancer patients.
van Agthoven T; Eijkenboom WMH; Looijenga LHJ
Cell Oncol (Dordr); 2017 Aug; 40(4):379-388. PubMed ID: 28612337
[TBL] [Abstract][Full Text] [Related]
31. Serum lactate dehydrogenase and human choriogonadotrophin in seminoma.
Fosså A; Fosså SD
Br J Urol; 1989 Apr; 63(4):408-15. PubMed ID: 2653557
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the M371-Test Under Real-life Conditions for Diagnosis and Follow Up of Testicular Germ Cell Tumors.
Pycha S; D'Elia C; Mian C; Schwienbacher C; Hanspeter E; Palermo M; Pycha A; Danuser H; Trenti E
Anticancer Res; 2023 Apr; 43(4):1649-1653. PubMed ID: 36974797
[TBL] [Abstract][Full Text] [Related]
33. Serum estradiol as a tumour marker for non-seminomatous germinal cell tumours (NSGCT) of the testis.
Uysal Z; Bakkaloğlu M
Int Urol Nephrol; 1987; 19(4):415-8. PubMed ID: 2448261
[TBL] [Abstract][Full Text] [Related]
34. [French ccAFU guidelines - update 2020-2022: testicular germ cell tumors].
Murez T; Fléchon A; Savoie PH; Rocher L; Camparo P; Morel-Journel N; Ferretti L; Méjean A
Prog Urol; 2020 Nov; 30(12S):S280-S313. PubMed ID: 33349427
[TBL] [Abstract][Full Text] [Related]
35. The growth rate of metastatic nonseminomatous germ cell testicular tumours measured by marker production doubling time--II. Prognostic significance in patients treated by chemotherapy.
Price P; Hogan SJ; Bliss JM; Horwich A
Eur J Cancer; 1990 Apr; 26(4):453-7. PubMed ID: 1694087
[TBL] [Abstract][Full Text] [Related]
36. Alpha-fetoprotein (AFP) and human chorionic gonadotropin (HCG) in testicular germ cell tumours. A comparison of histologic and serologic occurrence of tumour markers.
Jacobsen GK
Acta Pathol Microbiol Immunol Scand A; 1983 May; 91(3):183-90. PubMed ID: 6190351
[TBL] [Abstract][Full Text] [Related]
37. [Testicular Cancer: Diagnostics, Therapy and Follow Up].
Kälin M; Mauti L; Pless M
Praxis (Bern 1994); 2016 May; 105(11):643-8. PubMed ID: 27223417
[TBL] [Abstract][Full Text] [Related]
38. [Stage-specific treatment for testicular germ cell tumours].
Heidenreich A; Bokemeyer C; Souchon R
Urologe A; 2009 Apr; 48(4):377-85. PubMed ID: 19252891
[TBL] [Abstract][Full Text] [Related]
39. The role of alkaline phosphatase isoenzymes as tumor markers for testicular germ cell tumors.
Koshida K; Nishino A; Yamamoto H; Uchibayashi T; Naito K; Hisazumi H; Hirano K; Hayashi Y; Wahren B; Andersson L
J Urol; 1991 Jul; 146(1):57-60. PubMed ID: 1711586
[TBL] [Abstract][Full Text] [Related]
40. Treatment and Outcome of Patients with Stage IS Testicular Cancer: A Retrospective Study from the Spanish Germ Cell Cancer Group.
Aparicio J; Sánchez-Muñoz A; Ochenduszko S; Gumà J; Fernández-Aramburo A; García Del Muro X; Quiroga V; Sastre J; Alonso-Gordoa T; Sagastibelza N; Maroto P; Gómez de Liaño A; Vázquez S; Diz P; Durán I; Domenech M; Pinto A; Hernández A; González-Billalabeitia E; Terrasa J
J Urol; 2019 Oct; 202(4):742-747. PubMed ID: 31163007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]